Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Walgreens Boots Alliance will name will name former Express Scripts chief executive Tim Wentworth as the drugstore giant's new chief executive officer.

Walgreens Taps Former Express Scripts Chief Tim Wentworth As New CEO

NEW YORK — Some Walgreens pharmacy staff walked off the job this week over concerns that working conditions are putting employees and patients at risk.

Walgreens pharmacy staffers stage walkouts over work conditions

Apple

Here is a short-term map to market direction. A short-term high and a pullback are expected to be followed by Q4 strength.

Stocks This Week: Sell Short Walgreens Boots And Buy Apple

Retail pharmacists and technicians around the country say they're overworked, underpaid and fed up.

Why Walgreens pharmacy workers are walking off the job

Baxter

Boston Properties

Fidelity National Information

SPDR Portfolio Long Term Treasury ETF

AT&T

V.F.

Warner Bros Discovery Inc

If you own long-term Treasurys, you'd be hard-pressed to find a worse investment the S&P 500. But it's possible.

Only 7 Stocks Burn Investors Worse Than Long-Term Treasurys

Walgreens Boots Alliance Inc (NASDAQ:WBA) reports its fourth-quarter and full-year 2023 results ahead of the opening bell on October 12, 2023, and analysts are bracing for another sharp decline in earnings. The drugstore operator has had to contend with a weak consumer environment, as well as increased competition from online pharmacies.

Walgreens likely to deliver another sickly earnings report for 4Q

Pharmacy staff at dozens of Walgreens locations have walked off the job over workplace conditions. The work stoppage follows a similar protest at several CVS stores, and could stretch into Wednesday.

Your local Walgreens might be closed this week. Here's why pharmacy workers are walking off the job.

Employees at Walgreens, one of the largest drugstore chains in the US, are staging walkouts to protest what they describe as unsafe working conditions that compromise customer health. Scheduled between October 9-11, the action has been organized by pharmacy staff including pharmacists, technicians, and support staff.

Walgreens workers walk out in "pharmageddon" protests at understaffing

Employees at major pharmacy chains like CVS and Walgreens say their demanding work schedules are bad not only for them but for patients. Pharmacists and other employees at Walgreens stores across the country have reportedly pledged to walk out of work this week due to harsh work conditions in the chain's pharmacy departments.

‘Pharmageddon': Walgreens walkout this week could make your prescriptions hard to get

Pharmacy staff at some Walgreens stores across the country are say they will lock their gates and walk out Monday, citing harsh working conditions that make it difficult to safely fill prescriptions.

Walgreens walkout: 5 things you need to know

Walgreens Boots Alliance is one of the key players in the healthcare industry and one of the world's largest retail pharmacies, headquartered in Deerfield, serving millions of people each year. On October 12, 2023, the Company will publish a report for the fourth quarter of fiscal 2023, which, in our opinion, will again upset investors. Walgreens Boots Alliance's revenue is expected to decline in the fourth quarter due to lower COVID-19 vaccinations and testing.

Walgreens Boots Alliance Faces Disappointment: Prepare For More Struggles In Sight

Some employees plan to walk out for one day, while others expect to close their pharmacies for all three, the network said, citing employees in three states.

Walgreens pharmacy employees plan walkout at US stores: report

Pharmacy employees at some U.S. Walgreens stores, including pharmacists, technicians and support staff, are planning a walkout between Oct. 9 and 11, CNN reported on Friday, citing an organizer.

Pharmacy employees at US Walgreens stores plan walkout -CNN

Employees at two of the largest drugstore chains in the United States say harsh working conditions make it difficult to safely fill prescriptions, which could put the health of their customers at risk. Now, they're demanding change by staging a series of walkouts across the country.

Walgreens walkout: Your pharmacy might be closed next week

Domino's Pizza

PepsiCo

CNBC's Jim Cramer on Friday told investors what to focus on going into the week ahead which will see the beginning of earnings season.

Cramer's week ahead: Earnings season kicks off with Domino's, Walgreens and PepsiCo

2 Potentially Explosive Stocks to Buy in October

Amcor Plc

Franklin Resources

Essex Property Trust

Federal Realty Investment Trust

Genuine Parts

Coca-Cola

NextEra Energy

Realty Income Corp

Stanley Black & Decker

Sysco

Target

T. Rowe Price Group

"Dividend Aristocrats in the S&P 500 Index

4 Dividend Aristocrat Flash Buys For October While 6 Get Closer

Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Walgreens Boots Alliance (WBA) Q4 Earnings Expected to Decline

Rising interest rates are causing companies' fundamentals to deteriorate, increasing the risk of dividend cuts. Long-term rates jumped almost 1% in 3 months, the fastest in over 20 years. Borrowing costs for investment grade companies are up 8% to 14%. Walgreens Boots Alliance, Inc. is at risk of a dividend cut as it faces a significant debt cliff through 2025.

Walgreens' Dividend Could Be Toast So Buy These 9% Yielding SWANs Instead

Johnson & Johnson

Verizon

The Dow Jones Industrial Average is home to 30 generally profitable, diverse, multinational businesses. A pullback in the Dow from its 2023 high is the perfect opportunity for long-term investors to buy into high-quality companies at a discount.

3 Historically Cheap Dow Stocks to Buy Hand Over Fist in October

Amgen

Boeing

Salesforce

Chevron

Disney

Dow Inc

Goldman Sachs

Intel

JPMorgan Chase & Co

McDonald's

Microsoft

NIKE

"The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Sector representation is also a consideration.”–Dow Jones & Co. The highest-yield 10 stocks are October's Dogs of the Dow: JNJ, AMGN, KO, GS, CVX, IBM, DOW, MMM, VZ, and WBA averaged a 4.99% annual yield. Thirty Dow stocks represent nine of eleven sectors. Dow Jones tracks utilities as a separate index and omits real estate. Broker top-ten target-estimated October net-gains ranged 17.91%-45.47%, topped by WBA 10/2/23.

October Dogs Of The Dow: 3 Buyable, 7 Watchable

In a turn of events that proves persistence can indeed pay off, Neighbourly Pharmacy is contemplating a return to private ownership. Its largest shareholder, Persistence Capital Partners, has proposed to take the firm private at a price of $20.50 per share, valuing the business at just over $900 million.

Persistence pays off for Neighbourly Pharmacy key investor

For many years, the Dow Jones industrial average ruled the investing world, before the advent of electronic and computer-driven trading.

5 Damaged Dow Jones Industrial Dividend Leaders Have Huge 2024 Comeback Potential

Buying dividend stocks is a smart way to counter near-term economic uncertainty. One well-known, supercharged dividend stock is receiving little love from Wall Street.

Meet the Nearly 9%-Yielding Dividend Stock Wall Street Hates That I've Quadrupled My Position in Recently

Devon Energy

KeyCorp

Altria

PG&E

Pioneer Natural Resources

Simon Property Group

Truist Financial

It's possible to score 5% yields on CDs. So to even consider dividend paying S&P 500 stocks the yield had better be impressive.

News for Walgreens Stock (WBA)